Galapagos NV GXE-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 9:10 AM CEST
53.10quote price arrow down-1.50 (-2.75%)
52 week range
41.05 - 66.21
Loading...
  • Open53.10
  • Day High53.10
  • Day Low53.10
  • Prev Close57.36
  • 52 Week High66.21
  • 52 Week High Date06/11/21
  • 52 Week Low41.05
  • 52 Week Low Date12/06/21

Key Stats

  • Market Cap3,914.32M
  • Shares Out65.65M
  • 10 Day Average Volume3,173.4
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change10.72

KEY STATS

  • Open53.10
  • Day High53.10
  • Day Low53.10
  • Prev Close57.36
  • 52 Week High66.21
  • 52 Week High Date06/11/21
  • 52 Week Low41.05
  • 52 Week Low Date12/06/21
  • Market Cap3,914.32M
  • Shares Out65.65M
  • 10 Day Average Volume3,173.4
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change10.72

RATIOS/PROFITABILITY

  • EPS (TTM)-1.59
  • P/E (TTM)-33.40
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Galapagos NV

There is no recent news for this security.

Profile

MORE
Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company aims to develop a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. In...
Paulus Stoffels
Chairman of the Board, Chief Executive Officer
Bart Filius
President, Chief Financial Officer, Chief Operating Officer, Member of the Management Board
Address
Generaal De Wittelaan 3
Malines (mechelen)
2800
Belgium